{"id":4758,"date":"2023-04-24T09:46:22","date_gmt":"2023-04-24T09:46:22","guid":{"rendered":"https:\/\/www.cueim.org\/?p=4758"},"modified":"2023-06-22T08:29:54","modified_gmt":"2023-06-22T08:29:54","slug":"lesperienza-micoperi-blue-growth-con-la-coltivazione-di-microalghe-e-frutto-di-una-ricerca-applicata-italiana-diventata-un-esempio-di-clustering-per-ottenere-prodotti-di-alto-valore","status":"publish","type":"post","link":"https:\/\/www.cueim.org\/en\/lesperienza-micoperi-blue-growth-con-la-coltivazione-di-microalghe-e-frutto-di-una-ricerca-applicata-italiana-diventata-un-esempio-di-clustering-per-ottenere-prodotti-di-alto-valore\/","title":{"rendered":"The Micoperi Blue Growth experience with microalgae cultivation. A successful follow-up of an Italian applied research that became a clustering example to obtain high-value products."},"content":{"rendered":"

\"\"<\/p>\n

In the framework of the ENI CBC MED<\/a> project MedArtSal<\/a>, last January CUEIM, MedArtSal Lead Beneficiary, conducted an interesting interview with Federica Abbondanzi<\/strong>, Researcher at Micoperi Blue Growth<\/a>, an Italian startup acting in the field of biotechnology research and the development and marketing of natural products deriving from microalgae, with a specific focus on Spirulina. By using it, they obtain several derived products for cosmetic, gastronomic and nutraceutical use.<\/p>\n

Tiziana Campisi<\/strong>, Project Manager at CUEIM, conducted the interview at the company headquarters in Ravenna. Mrs. Abbondanzi welcomed her to the greenhouses where the production takes place.<\/p>\n

\"\"CUEIM interviews Federica Abbondanzi – Micoperi Blue Growth<\/span><\/p>\n

As MedArtSal project Lead Beneficiary, CUEIM considers that Micoperi BG successful example of research and development activities in this field could help both MedArtSal project managers and the project pilot actions salinas<\/strong> to learn more about the right path and process to turn the promising activities started in their saltpans into successful opportunities for their businesses.<\/p>\n

The MedArtSal project experience allowed us to understand that microalgae production could represent another key factor in the diversification strategy of the salinas\u2019 activities<\/strong>. The video interview was also shown during the MedArtSal clustering workshops<\/strong> that took place in Tunisia last March, in the framework of the interesting insights shared about the gastronomic relevance of salt and other products from salinas.<\/p>\n

Namely, the interview focused on 5 main questions<\/strong>, that allowed to better understand the experience of Micoperi Blue Growth in microalgae production, its linkage with EU Blue Growth strategies and policies, and their potential touchpoints and exchange with the MedArtSal project.<\/p>\n

The interview<\/strong><\/h5>\n

TC \u2013 CUEIM<\/strong>: In the framework of EU legislation, Blue Growth<\/strong> represents \u201ca long-term strategy in support of sustainable growth of the marine and maritime sectors applied by the European Commission (DG MARE<\/strong>) to harness the untapped potential of Europe\u2019s oceans, seas and coasts as drivers for the European green economy with a great potential for innovation, improved competitiveness and quality jobs aiming at achieving the goals of the Europe 2020 strategy for smart, sustainable and inclusive growth<\/strong>.<\/em>\u201d Which is the Micoperi Blue Growth contribution to this strategy and how do you consider the microalgae production instrumental to its goals?<\/strong><\/p>\n

FA \u2013 Micoperi BG<\/strong>: Our strategy aims to optimize both production processes and products in order to meet our stakeholders, who increasingly demand awareness and commitment to environmental issues. Our researcher\u2019s work has allowed the production of algal biomass<\/strong> with a significantly higher level of quality and sustainability,<\/strong> than other Italian and international industrial productions. It is also crucial to continue to feed the internal research to ensure an entirely Made in Italy supply chain<\/strong>.<\/p>\n

\"\"European Commission Blue Growth Initiative Infographic<\/p>\n

TC – CUEIM<\/strong>: In some of the MedArtSal pilot actions, such as the one of Roqueta y Preciosa Salinas<\/strong> in the Natural Park of the Bay of Cadiz in Spain, the cultivation of Spirulina<\/strong> has become a way to diversify the activities while preserving the role of the artisanal salt production. This has an immediate impact on their activities since this type of microalgae is also included in the salinas\u2019 restaurant menu. If we consider the process that allows to bring from the microalgae cultivation to the sale of derived products, and according to your experience, which would be the key points for sustainable and successful results?<\/strong><\/p>\n

\"\"MedArtSal project partners visiting the Spirulina Cultivation site at Preciosa y Roqueta Salinas – Cadiz – Spain<\/p>\n

FA \u2013 Micoperi BG<\/strong>: The investments of the past 6 years have allowed to build a production protocol aimed at obtaining qualitatively excellent microalgal biomass<\/strong>, whose certified and guaranteed agri-food chain (UNI EN ISO 22005:2008) expresses the highest security: genetic certification of the matrix, titration of each lot for a greater guarantee in all sectors of use, including pharmaceutical, medical, cosmetic and food.<\/p>\n

The fields of activity<\/strong> of our research and development are many and, in recent years, we have achieved important results:<\/p>\n